Cardiac risk assessment: Matching intensity of therapy to risk

Cardiology Clinics

Volumn 24, Issue 1 SPEC. ISS., 2006, Pages 67-78

  Vesely, Mark R ^a   Kelemen, Mark D ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC ACID DERIVATIVE; TIROFIBAN;

ACUTE HEART INFARCTION; BLEEDING; BLOOD CLOT LYSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONSENSUS; COST EFFECTIVENESS ANALYSIS; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; ELECTROCARDIOGRAM; HEALTH CARE QUALITY; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL DECISION MAKING; META ANALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; STROKE; SYSTEMATIC REVIEW; THROMBOCYTOPENIA;

EID: 28544445339     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccl.2005.09.010     Document Type: Review

References (31)

1. P.G.C. Mourouga, and K.M. Rowan Does it fit? Is it good? Assessment of scoring systems Curr Opin Crit Care 6 2000 176
2. P.H. Stone, B. Thompson, and H.V. Anderson Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry JAMA 275 1996 1104
3. D.L. Bhatt, M.T. Roe, and E.D. Peterson Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative JAMA 292 2004 2096
4. M.S. Sabatine, D.A. Morrow, and J.A. de Lemos Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide Circulation 105 2002 1760
5. E.M. Antman, M. Cohen, and P.J. Bernink The TIMI risk score for unstable angina/non-st elevation MI: A method for prognostication and therapeutic decision making JAMA 284 2000 835 842
6. E. Boersma, K.S. Pieper, and E.W. Steyerberg Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators Circulation 101 2000 2557
7. C.B. Granger, R.J. Goldberg, and O. Dabbous Predictors of hospital mortality in the global registry of acute coronary events Arch Intern Med 163 2003 2345
8. C.M. Gibson, D.S. Pinto, and S.A. Murphy Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality J Am Coll Cardiol 42 2003 1535 1543
9. O. Bazzino, J.J. Fuselli, and F. Botto Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes Eur Heart J 25 2004 859
10. J.A. de Lemos, D.A. Morrow, and C.M. Gibson The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies J Am Coll Cardiol 40 2002 238
11. D.A. Morrow, N. Rifai, and E.M. Antman C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: A TIMI 11a substudy. Thrombolysis in myocardial infarction J Am Coll Cardiol 31 1998 1460 1465
12. M.S. Sabatine, D.A. Morrow, and R.P. Giugliano Association of hemoglobin levels with clinical outcomes in acute coronary syndromes Circulation 111 2005 2042
13. D.L. Bhatt, D.P. Chew, and A.M. Lincoff Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromes Am J Cardiol 92 2003 136
14. E. Braunwald Unstable angina. A classification Circulation 80 1989 410
15. L. Campeau Grading of angina pectoris [letter] Circulation 54 1976 522
16. L. Campeau The Canadian Cardiovascular Society grading of angina pectoris revisited 30 years later Can J Cardiol 18 2002 371
17. E. Braunwald Unstable angina: an etiologic approach to management Circulation 90 1998 2219
18. A.H. Wu, F.S. Apple, and W.B. Gibler National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases Clin Chem 45 1999 1104
19. F.E. Harrell Jr., K.L. Lee, and D.B. Mark Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361
20. E.M. Antman, C.H. McCabe, and E.P. Gurfinkel Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarcion (TIMI) 11B trial Circulation 100 1999 1593
21. M.S. Sabatine, and E.M. Antman The thrombolysis in myocardial infarction risk score in unstable angina/non-ST-segment elevation myocardial infarction J Am Coll Cardiol 41 2003 89S
22. M. Cohen, C. Demers, and E.P. Gurfinkel A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group N Engl J Med 337 1997 447
23. P. Theroux, H. Ouimet, and J. McCans Aspirin, heparin, or both to treat acute unstable angina N Engl J Med 319 1988 1105
24. C.P. Cannon, W.S. Weintraub, and L.A. Demopoulos Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N Engl J Med 344 2001 1879
25. M. Mitka Results of CURE trial for acute coronary syndrome JAMA 285 2001 1828
26. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ 308 1994 81
27. E. Braunwald, E.M. Antman, and J.W. Beasley ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) J Am Coll Cardiol 40 2002 1366
28. A.T. Yan, P. Jong, and R.T. Yan Clinical trial-derived risk model may not generalize to real-world patients with acute coronary syndrome Am Heart J 148 2004 1020
29. C.M. Gibson, R.L. Dumaine, and E.V. Gelfand Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials Eur Heart J 25 2004 1998
30. F.S. Apple, A.H. Wu, and J. Mair Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome Clin Chem 51 2005 810
31. R.M. Califf, E.D. Peterson, and R.J. Gibbons Integrating quality into the cycle of therapeutic development J Am Coll Cardiol 40 2002 1895